ONCORAL PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 35481214
Teknikerbyen 5, Søllerød 2830 Virum
moc@ascelia.com
tel: 45484448
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -3 856.44 | -13 819.76 | -7 461.59 | - 996.23 | - 366.79 |
| EBIT | -3 856.44 | -13 819.76 | -7 461.59 | - 996.23 | - 366.79 |
| Other financial income | 446.76 | 393.56 | 560.71 | 297.85 | |
| Other financial expenses | - 348.38 | -1 102.64 | -3 494.76 | -2 442.53 | -4 053.71 |
| Pre-tax profit | -4 204.82 | -14 475.65 | -10 562.79 | -2 878.04 | -4 122.65 |
| Income taxes | 746.55 | 2 657.55 | 1 355.90 | 210.80 | 64.81 |
| Net earnings | -3 458.28 | -11 818.10 | -9 206.89 | -2 667.24 | -4 057.83 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 87.50 | 87.50 | 87.50 | 87.50 | 87.50 |
| Intangible assets total | 87.50 | 87.50 | 87.50 | 87.50 | 87.50 |
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 35.39 | 68.21 | 45.47 | 27.74 | |
| Current other receivables | 178.31 | 989.82 | 342.25 | 17.86 | 26.96 |
| Current deferred tax assets | 834.19 | 2 658.37 | 1 355.90 | 210.80 | 64.81 |
| Short term receivables total | 1 047.89 | 3 716.40 | 1 743.62 | 256.39 | 91.77 |
| Cash and bank deposits | 1 586.34 | 11 082.08 | 7 766.16 | 9 139.15 | 499.58 |
| Cash and cash equivalents | 1 586.34 | 11 082.08 | 7 766.16 | 9 139.15 | 499.58 |
| Balance sheet total (assets) | 2 721.73 | 14 885.97 | 9 597.28 | 9 483.05 | 678.85 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 145.92 | 145.92 | 145.92 | 145.92 | 145.92 |
| Retained earnings | -2 127.70 | -5 585.97 | -17 404.07 | -26 610.96 | -29 278.21 |
| Profit of the financial year | -3 458.28 | -11 818.10 | -9 206.89 | -2 667.24 | -4 057.83 |
| Shareholders equity total | -5 440.05 | -17 258.16 | -26 465.04 | -29 132.29 | -33 190.12 |
| Non-current owed to group member | 7 003.52 | 26 653.25 | 28 748.02 | 28 361.64 | 32 415.35 |
| Non-current liabilities total | 7 003.52 | 26 653.25 | 28 748.02 | 28 361.64 | 32 415.35 |
| Current trade creditors | 112.06 | 318.38 | 169.42 | 24.68 | 65.18 |
| Current owed to group member | 996.20 | 4 977.74 | 6 966.45 | 10 163.79 | 1 355.44 |
| Other non-interest bearing current liabilities | 50.00 | 194.76 | 178.44 | 65.23 | 33.00 |
| Current liabilities total | 1 158.27 | 5 490.88 | 7 314.31 | 10 253.69 | 1 453.62 |
| Balance sheet total (liabilities) | 2 721.73 | 14 885.97 | 9 597.28 | 9 483.05 | 678.85 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.